Sun Pharma’s $11.8 Billion Organon Deal Drives India’s M&A Value to Four-Year High

How Did Sun Pharma’s Organon Deal Transform India’s M&A Market?

India’s mergers and acquisitions (M&A) market recorded its highest quarterly value in four years during the April–June 2026 quarter, driven by a handful of blockbuster transactions led by Sun Pharmaceutical Industries’ $11.75 billion acquisition of Organon & Co. The landmark deal emerged as the largest transaction of the quarter, propelling overall M&A activity despite a decline in the number of deals.

According to Grant Thornton Bharat’s Q2 2026 Dealtracker, India recorded 565 M&A and private equity (PE) transactions worth $36.3 billion during the quarter. While total deal volumes fell 18% compared with the previous quarter, deal values surged 127%, highlighting the growing impact of large-ticket strategic acquisitions.

Which Mega Deals Drove India’s Record M&A Value?

A small number of billion dollar transactions dominated India’s dealmaking landscape during the quarter. Besides Sun Pharma’s acquisition of Organon, the largest transactions included Bharti Airtel’s $2.97 billion acquisition of a 16% stake in Airtel Africa Plc, EPL Ltd’s $2 billion transaction involving Indovida India Pvt Ltd, VINCI Highways’ $1.6 billion acquisition of Safeway Concessions’ toll road portfolio, and GMR Group’s $1.05 billion stake sale in GMR Airports Holding Ltd.

Together, these five transactions accounted for nearly 69% of the total M&A value recorded during the quarter, underlining how a few mega deals significantly influenced overall market activity.

The concentration of large transactions also reflects increasing confidence among Indian corporates in executing high-value strategic acquisitions both domestically and overseas.

Kunal Kapoor Launches MetaGO to Tackle Obesity With AI and Doctor-Led Metabolic Care

Why Did M&A Activity Outperform Private Equity Investments?

M&A emerged as the primary driver of deal value during the quarter. India witnessed 240 M&A transactions worth $27.9 billion, representing the highest quarterly M&A value since Q2 2022, when the landmark HDFC-HDFC Bank merger was announced.

Although M&A volumes declined 12% sequentially, transaction values surged 302%, largely due to several outbound acquisitions by Indian companies. Outbound transactions alone accounted for 84% of the total M&A value, highlighting Indian companies’ growing appetite for international expansion.

In comparison, private equity activity moderated during the quarter. Investors completed 325 PE deals worth $8.4 billion, reflecting a 22% decline in volumes and an 8% fall in value compared with Q1 2026. However, the average investment size increased as investors focused on fewer but larger transactions.

Which Sectors Attracted the Highest Deal Activity?

The report showed that Retail and Consumer led deal activity by volume with 95 transactions, followed by IT & ITES with 80 deals and Banking & Financial Services with 62 transactions.

By value, however, Pharma, Healthcare & Biotech emerged as the clear leader, recording $13.7 billion in transactions, driven primarily by Sun Pharma’s acquisition of Organon.

Other sectors witnessing significant deal activity included Manufacturing, which generated $3.5 billion, Telecom with $3 billion, and Infrastructure Management, which recorded $2.9 billion, reflecting continued investor interest in strategic infrastructure assets.

Meanwhile, public market fundraising presented mixed trends. IPO activity softened to 11 listings raising $1.1 billion, while Qualified Institutional Placements (QIPs) gained momentum with 16 issuances raising $2.3 billion, indicating stronger reliance on secondary capital raising.

What Does This Mean for India’s Dealmaking Outlook?

The second quarter of 2026 highlights a clear divergence in India’s investment landscape. While overall deal volumes moderated amid global economic uncertainty, high-value strategic acquisitions continued to drive record transaction values.

According to Shanthi Vijetha, Partner – Growth at Grant Thornton Bharat, the surge in outbound M&A demonstrates growing confidence among Indian companies pursuing global expansion, even as domestic investments and private equity activity remain relatively measured.

Going forward, India’s M&A market is expected to remain active, particularly in sectors such as pharmaceuticals, technology, manufacturing, telecom, and infrastructure. If global macroeconomic conditions remain stable, strategic acquisitions and cross-border transactions are likely to continue shaping India’s corporate growth story over the coming quarters.